Company Overview
BIO-key International, Inc. operates within the Industrials sector, specifically focusing on the Security & Protection Services industry, where it develops and markets fingerprint identification biometric technology and software solutions alongside enterprise-ready identity access management solutions. These offerings are designed to serve commercial, government, and education sectors across both the United States and international markets, with a primary product including the BIO-key PortalGuard solution. The company maintains a significant operational footprint supported by a workforce of 41 employees, generating a trailing twelve-month revenue of $6.32M. This combination of specialized biometric technology and a relatively small employee base results in a market capitalization of $6.22M, indicating that the firm operates as a micro-cap entity with limited scale relative to larger industrials peers. The valuation metrics suggest a company that has achieved a certain level of product-market fit in its niche security sector, yet its market capitalization remains constrained, reflecting the early-stage nature of its growth trajectory and the specific challenges associated with its financial performance.
Financial Health
The company's financial statements for the trailing twelve months reveal a revenue of $6.32M, a net income of $-4,253,287, and an EBITDA of $-3,512,588. The substantial gap between the positive revenue figure and the deeply negative net income highlights a cost structure where operating expenses significantly outpace gross profit generation, a common characteristic in high-growth technology firms facing scaling challenges. Free cash flow stands at $-1,675,812, indicating that the company is currently burning cash, which limits its financial flexibility and reliance on external capital sources or existing liquidity reserves. Gross margin is reported at 78.4%, suggesting that the core biometric technology products carry high pricing power or low direct manufacturing costs, yet the operating margin of -57.6% and profit margin of -67.3% demonstrate that general and administrative expenses are eroding profitability. On the balance sheet, the company holds $2.04M in cash against $1.46M in debt, resulting in a debt-to-equity ratio of 24.21. While the company holds more cash than debt, the leverage ratio implies a capital structure that is sensitive to equity dilution or refinancing risks if earnings do not stabilize. The current ratio is 1.26, which indicates that the company possesses sufficient current assets to cover its short-term liabilities, though the buffer is relatively narrow for a firm with ongoing cash burn. Return on Equity is -137.7% and Return on Assets is -29.4%, metrics that reveal that management is currently unable to generate positive returns on the capital invested in the business, signaling a period of financial distress or a prolonged investment phase that has not yet yielded profitability.
Valuation Assessment
The valuation multiples for BIO-key International, Inc. present a mixed picture, with a P/E Ratio (TTM) listed as N/A due to the lack of positive earnings, and a Forward P/E of -1.79. The negative forward P/E suggests that analysts or market participants expect earnings to remain negative in the near term, or that the current valuation model relies on revenue multiples rather than earnings power given the current loss-making status. The price-to-book ratio is 0.69, indicating that the market values the company at a significant discount to its tangible book value, which often occurs with distressed assets or firms facing significant operational hurdles. Additionally, the price-to-sales ratio is 0.98, while the EV/EBITDA stands at -1.60, suggesting that investors are pricing the stock based on its revenue potential and asset base rather than earnings power. The stock has a 52-week high of $1.97 and a 52-week low of $0.51, placing the current trading range within a wide band of volatility typical for small-cap securities with negative earnings. With a beta of 0.44, the company exhibits lower price volatility relative to the broader market, meaning its share price tends to move less dramatically than the overall market index, which can offer a degree of stability despite the underlying financial losses.
Growth & Income
Revenue growth year-over-year is recorded at -27.7%, while earnings growth is listed as N/A due to the absence of positive prior-year earnings for comparison. The negative revenue growth indicates a contraction in the company's top line, which is a critical concern as it suggests a decline in demand or a loss of market share within the security services sector. Since the company is not a dividend payer, there is no dividend yield or payout ratio to evaluate for sustainability; instead, the company must reinvest any potential future earnings or utilize its cash reserves to fund operations and potentially return to profitability. The overall growth and income profile for BIO-key International, Inc. is currently characterized by negative revenue momentum and an inability to generate positive earnings or cash flow, presenting a challenging environment for value creation until operational efficiency improves and top-line growth stabilizes.